Multiple Sclerosis Clinical Trials Offer New Treatments For No Cost!

Clinical Trials are the last stage of research before drugs reach the market, may have better results than existing drugs.

The cost of life saving drugs skyrocketed in 2016 as evident by huge price hikes for Epi-Pen and Deraprim. In the most extreme cases prices have increased by 100-fold and now cost people $10,000's to $100,000's and more every year.

The trend of rising prices isn't showing signs of slowing down either. Medicare subsidies and insurance can't be counted on to cover the entire cost of new medications.

Furthermore, insurance deductibles have reset for many at the start of 2017 along with higher rates.

As a result of the rising prices, clinical trials have become a more attractive option for many by offering new and experimental treatments at no-cost.

Clinical trials are an important part of clinical research. In fact, many trials will pay participants for time and travel, as well as other benefits such as free study related medical care.

There are several clinical trials currently enrolling for MS, RRMS, and Spasticity due to MS.

Participants are urgently needed for MS, including RRMS, and Spasticity due to MS consider participating in a clinical research study.

One of the leading clinical trial providers in southern California, CNS Network, has several enrolling MS studies. With locations in Garden Grove, Long Beach, and Torrance, as well as transportation services for patients. CNS can cover the Greater Los Angeles area, North Orange County, and Inland Empire.

The benefits of participating in a clinical research study include; - No insurance needed - Compensation available for time and travel - Opportunity to experience new treatments and drugs that may be better than what is on the market - Help researchers develop new treatments and potential cures

Last year saw several major breakthroughs for clinical research. A clinical study testing Ocrelizumab for relapsing multiple sclerosis beat exceptions and marked a major landmark towards a cure. Other advances for migraines and Alzheimer's have made advances thanks to clinical research volunteers.

To continue advancing clinical research, companies need overcome the hurdle of recruitment-finding the right participants. While many have heard or know of clinical trials, few actually participate. Without research volunteers, studies can't be completed and potential life-saving drugs are delayed from reaching market.